As of 2026-04-02, the Relative Valuation of ALX Oncology Holdings Inc (ALXO) is (18.12) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.98 USD, the upside of ALX Oncology Holdings Inc based on Relative Valuation is -1015.1%.
The range of the Relative Valuation is (16.49) - (20.62) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.3x - 27.9x | 24.7x |
| Forward P/E multiples | 21.2x - 26.7x | 22.2x |
| Fair Price | (16.49) - (20.62) | (18.12) |
| Upside | -932.8% - -1141.2% | -1015.1% |
| Date | P/E |
| 2026-03-13 | -2.57 |
| 2026-03-12 | -2.61 |
| 2026-03-11 | -2.78 |
| 2026-03-10 | -2.64 |
| 2026-03-09 | -2.76 |
| 2026-03-06 | -2.86 |
| 2026-03-05 | -2.76 |
| 2026-03-04 | -2.83 |
| 2026-03-03 | -2.68 |
| 2026-03-02 | -2.74 |
| 2026-02-27 | -2.73 |
| 2026-02-26 | -3.04 |
| 2026-02-25 | -3.13 |
| 2026-02-24 | -3.17 |
| 2026-02-23 | -3.13 |
| 2026-02-20 | -3.17 |
| 2026-02-19 | -3.36 |
| 2026-02-18 | -3.00 |
| 2026-02-17 | -2.94 |
| 2026-02-13 | -2.86 |
| 2026-02-12 | -3.11 |
| 2026-02-11 | -3.21 |
| 2026-02-10 | -3.30 |
| 2026-02-09 | -3.03 |
| 2026-02-06 | -2.65 |
| 2026-02-05 | -2.67 |
| 2026-02-04 | -2.60 |
| 2026-02-03 | -2.42 |
| 2026-02-02 | -2.17 |
| 2026-01-30 | -2.25 |
| 2026-01-29 | -2.03 |
| 2026-01-28 | -1.77 |
| 2026-01-27 | -1.94 |
| 2026-01-26 | -1.92 |
| 2026-01-23 | -1.81 |
| 2026-01-22 | -1.90 |
| 2026-01-21 | -1.90 |
| 2026-01-20 | -1.71 |
| 2026-01-16 | -1.51 |
| 2026-01-15 | -1.57 |
| 2026-01-14 | -1.72 |
| 2026-01-13 | -1.93 |
| 2026-01-12 | -1.86 |
| 2026-01-09 | -1.75 |
| 2026-01-08 | -1.60 |
| 2026-01-07 | -1.53 |
| 2026-01-06 | -1.40 |
| 2026-01-05 | -1.45 |
| 2026-01-02 | -1.49 |
| 2025-12-31 | -1.46 |